• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.31% Nasdaq Up 0.98%

    Omeros Corporation (OMER)

    -NasdaqGM
    23.36 Up 3.33(16.63%) Jan 29, 4:00PM EST
    |After Hours : 23.36 0.00 (0.00%) Jan 29, 4:46PM EST
    Add to Portfolio
    Prev Close:20.03
    Open:21.75
    Bid:22.82 x 200
    Ask:N/A
    1y Target Est:36.20
    Beta:2.65
    Earnings Date:Mar 11 - Mar 16 (Est.)
    Day's Range:21.50 - 24.03
    52wk Range:9.76 - 25.84
    Volume:1,029,523
    Avg Vol (3m):422,511
    Market Cap:795.99M
    P/E (ttm):N/A
    EPS (ttm):-1.70
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OMER

    Comparison

    Symbol% ChgMkt Cap
    OMERUp 16.63%795.99M
    ACADDown 0.54%3.10B
    ALKSUp 1.11%10.56B
    HRTXDown 0.24%243.94M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,292.66
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-2.25
    Quarterly EPS Est (Dec-14) :-0.64
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):-0.12

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes products targeting inflammation, coagulopathies, and disorders of the central nervous system. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback